Related by context. All words. (Click for frequent words.) 85 Randomized Double Blind 84 Oral Fingolimod 83 Controlled Trial 83 Study Evaluating 82 Double Blind Placebo 82 Controlled Study 82 Renal Cell Carcinoma 82 Prolongs Survival 82 Meets Primary Endpoint 82 Randomized Phase 82 Phase 2b Clinical Trial 81 Adjuvant Chemotherapy 81 Improves Survival 81 Improves Outcomes 81 Trial Evaluating 81 Subgroup Analysis 81 Relapsing Multiple Sclerosis 81 Patients Receiving 81 Patients Treated With 81 Clinical Trial Results 81 Chronic Hepatitis C 80 Antitumor Activity 80 Meta Analysis 80 Advanced Melanoma 80 Hormone Refractory Prostate Cancer 80 Placebo Controlled Trial 80 Pivotal Phase 80 Combination Treatment 80 Randomized Trials 80 Elderly Patients 80 Hypertensive Patients 80 Pediatric Patients 80 Previously Treated 80 Survival Benefit 79 Drug Combo 79 Shows Promising 79 Postmenopausal Women 79 Long Term Efficacy 79 Patients Undergoing 79 Novel Oral 79 Plus Ribavirin 79 Myeloma Patients 79 Treatment Naive Patients 79 Randomized Double blind 79 Artery Disease 79 Treated Patients 79 Adjuvant Treatment 79 Inhaled Corticosteroids 79 Drug Candidate 79 Drug Shows Promise 79 Single Dose 79 Metastatic Prostate Cancer 79 Peginterferon Alfa 2a 79 Cholesterol Lowering Drug 79 Relapsed Multiple Myeloma 79 Phase III Clinical Trial 79 Complicated Skin 79 Slow Progression 79 Statistically Significant 78 Metastatic Melanoma 78 Pharmacokinetic Study 78 Investigational Agent 78 Randomized Clinical Trial 78 Phase IIb Trial 78 Knee Osteoarthritis 78 Completes Patient Enrollment 78 Osteoporosis Drug 78 Advanced Prostate Cancer 78 Demonstrates Efficacy 78 Hormone Receptor Positive 78 Shows Efficacy 78 Preclinical Data 78 Placebo Controlled 78 Fungal Infections 78 Phase 2a Clinical Trial 78 Heart Failure Patients 78 Completes Enrollment 78 Patients Treated 78 Unfractionated Heparin 78 Prostate Cancer Patients 78 Insulin Glargine 78 Prospective Randomized 78 Study Showed 78 Patients Suffering 78 Phase 2b Trial 78 Lowers Risk 78 Randomized Phase II 78 Phase 2b Study 78 Combination REOLYSIN R 78 Naive Patients 77 Randomized Study 77 Stent Restenosis 77 Osteoporosis Drugs 77 Anti Tumor Activity 77 Lung Cancer Patients 77 Fracture Risk 77 Epilepsy Drug 77 Resistant Hypertension 77 Improved Survival 77 Improve Survival 77 Pivotal Phase III 77 Breast Cancer Recurrence 77 Proves Effective 77 Anti Tumor 77 Nicotine Vaccine 77 Appears Safe 77 Well Tolerated 77 Mouse Model 77 Infected Patients 77 Increased Mortality 77 Monotherapy 77 Initiate Phase III 77 Randomized Double Blind Placebo 77 Inflammatory Markers 77 Phase 2a Trial 77 Investigational Compound 77 Lung Cancer Survival 77 Investigational Drug 77 Chronic Hepatitis B 77 Treatment Naïve 77 Placebo Controlled Study 77 Clinical Outcome 77 Phase III Trial 77 Clinical Trial Evaluating 77 Anticancer Activity 77 Patient Enrollment 77 Previously Untreated 77 Cardiovascular Events 77 Randomized Controlled 77 Relapsed Refractory 77 Spectrum Pharmaceuticals Announces 77 Colorectal Cancer Patients 77 Lupus Drug 77 Topline Results 77 Treatment Reduces 77 Rheumatoid Arthritis Patients 77 Gastric Cancer 77 Lung Cancer Trial 77 Demonstrates Significant 77 Randomized Controlled Trial 77 Overactive Bladder 77 Metastatic Renal Cell Carcinoma 77 Adjuvant Therapy 77 Rotavirus Vaccine 77 Advanced Colorectal Cancer 77 Phase III Trials 77 Soft Tissue Sarcoma 77 JAK Inhibitor 77 Randomized Phase III 77 Brain Metastases 76 Newly Diagnosed Multiple Myeloma 76 Dose Escalation 76 Beneficial Effects 76 Multicenter Randomized 76 Metastatic Colorectal Cancer 76 Initiate Phase 76 Preclinical Study 76 Proven Effective 76 Premenopausal Women 76 Genes Linked 76 Adjunctive Therapy 76 Demonstrates Positive 76 Osteoporosis Treatment 76 Drug Prevents 76 Carotid Stenting 76 Statin Therapy 76 Sangamo BioSciences Announces 76 Effectively Treats 76 Treating Chronic 76 Shows Promise Against 76 Transdermal Patch 76 First Patient Dosed 76 Peginterferon 76 Randomized Controlled Trials 76 Combo Therapy 76 Colorectal Adenomas 76 Disease Progression 76 Is Well Tolerated 76 Ovarian Cancer Patients 76 Severe Sepsis 76 See CLINICAL PHARMACOLOGY 76 Confirmatory Phase 76 II Clinical Trial 76 Hepatitis C Infection 76 Critically Ill Patients 76 Renal Function 76 Refractory Hodgkin Lymphoma 76 Treatment Experienced 76 Invasive Breast Cancer 76 Lung Cancer Drug 76 Kidney Transplant Recipients 76 Diabetic Patients 76 Successfully Completes Phase 76 Kidney Transplant Patients 76 Lung Cancers 76 Predict Risk 76 Autologous Stem Cell Transplantation 76 Investigational Treatment 76 Pivotal Study 76 Androgen Deprivation Therapy 76 Versus Placebo 76 HCV Protease Inhibitor 76 Patients Enrolled 75 Newly Diagnosed 75 Neoadjuvant Chemotherapy 75 Dose Ranging 75 HER2 Positive Breast Cancer 75 Prophylactic Treatment 75 Partial Onset Seizures 75 Localized Prostate Cancer 75 Gene Mutation 75 Fewer Side Effects 75 Vildagliptin 75 FDA Okays 75 Venous Thromboembolism 75 Radical Prostatectomy 75 Cholesterol Drug 75 Multiple Myeloma Patients 75 Bare Metal Stents 75 Genes Predict 75 Secondary Hyperparathyroidism 75 ACE Inhibitors 75 Novel Mechanism 75 FDA Approvals 75 Malignant Melanoma 75 Hemodialysis Patients 75 Dose Finding 75 Antiviral Activity 75 Phase IIb Clinical Trial 75 Receives Orphan Drug Designation 75 Advanced Ovarian Cancer 75 Phase III Pivotal Trial 75 NDA Submission 75 Chronic Constipation 75 Diabetic Nephropathy 75 Advanced Renal Cell 75 Dose Ranging Study 75 Blood Pressure Drug 75 Protease Inhibitor 75 Liver Metastases 75 Orally Active 75 Liver Failure 75 Granted Orphan Drug 75 Intracranial Aneurysms 75 Multicenter Trial 75 Long Term Outcomes 75 Systemic Sclerosis 75 Gene Variation 75 Bone Metastases 75 Telaprevir VX 75 Randomized Clinical Trials 75 Node Positive 75 Erectile Dysfunction Drug 75 Drug Fails 75 Prognostic Factors 75 Significantly Reduced 75 Demonstrates Potent 75 Showed Significant 75 Hsp# Inhibitor 75 HER2 Positive 75 Breast Tumors 75 Kidney Function 75 Phase 1b Clinical Trial 75 Prognostic Significance 75 Desvenlafaxine Succinate 75 Subtypes 75 Vaccine Adjuvant 75 Genes Associated 75 Obesity Linked 75 Sustained Efficacy 75 Kidney Transplants 75 Reduced Risk 75 Platelet Inhibition 75 Gene Variants 75 Carcinomas 75 Tumor Growth 75 Breast Cancer Patients 75 Chronic Sinusitis 75 Recombinant Human 75 Sirolimus Eluting Stent 75 Therapy Improves 75 Brentuximab Vedotin SGN 74 Mylan Receives Approval 74 Demonstrated Significant 74 Genetic Variant 74 Treatment Shows Promise 74 Menopausal Women 74 Cutaneous T 74 Double Blind Randomized 74 Unresectable 74 Cell Lymphoma 74 Benign Prostatic Hyperplasia 74 Systematic Review 74 Multicenter Phase 74 Migraine Drug 74 Hepatocellular Carcinoma 74 Immunomedics Announces 74 Randomised Trial 74 Acute Pancreatitis 74 Potentially Fatal 74 Obese Patients 74 Epilepsy Drugs 74 Treatment Regimen 74 Slows Progression 74 Gene Variant 74 Phase III Clinical Trials 74 Follicular Lymphoma 74 Gout Drug 74 Combination Therapy 74 Antipsychotic Drugs 74 Stomach Cancer 74 Nymox NX 74 Relapsing Remitting Multiple Sclerosis 74 First Patient Enrolled 74 Dendritic Cells 74 Anti Inflammatory Drug 74 J Am Coll 74 Experimental Vaccine 74 Arthritis Drug 74 Sleep Disturbances 74 Reduces Pain 74 Breast Cancer Treatment 74 Bivalirudin 74 Castration Resistant Prostate Cancer 74 Pivotal Trial 74 Endothelial Function 74 Effective Than 74 Chronic Myeloid Leukemia 74 FDA Clears 74 Mg Usa 74 Treatment Naïve Patients 74 Ischemic Stroke 74 Serious Infections 74 Arterial Disease 74 Left Ventricular Hypertrophy 74 Cardiovascular Outcomes 74 Files IND 74 Vaccine Candidate 74 Premature Infants 74 Hepatitis C Patients 74 Bone Marrow Cells 74 Demonstrates Sustained 74 Gene Linked 74 Presents Positive 74 Low Dose 74 Study Demonstrates 74 Rheumatoid Arthritis Drug 74 Shown Effective 74 Zoledronic Acid 74 Kinase Inhibitor 74 Genes Identified 74 Paclitaxel Carboplatin 74 Immune Responses 74 Efficacy Trial 74 Multicenter Randomized Double 74 Increases Risk 74 Glycemic Control 74 Diabetic Neuropathic Pain 74 Phase IIa Clinical Trial 74 Randomized Placebo Controlled Trial 74 Increased Risk 74 Less Invasive 74 Vaginal Gel 74 Hormone Therapy 74 Nucleoside 74 Myelodysplastic Syndromes 74 Lupus Nephritis 74 ST Elevation Acute 74 Anticancer Drugs 74 Prospective Randomized Trial 74 Drug Resistant 74 Statin Drugs 74 Clostridium difficile Infection 74 Novel Antibiotic 74 Tiotropium 74 Often Misdiagnosed 74 Fixed Dose 74 Stent Implantation 74 Cardiac Function 74 Clinical Trial Data 74 Tolerability 73 Postmenopausal Osteoporosis 73 Initiates Clinical Trial 73 Antiviral Therapy 73 Hospital Acquired Pneumonia 73 Non Alcoholic Steatohepatitis 73 Cardiac Resynchronization 73 Novel Inhibitor 73 Severe Asthma 73 Pulmonary Arterial Hypertension 73 Tezampanel 73 Treatment Resistant 73 Antiviral Drugs 73 Receptor Agonist 73 Cognitive Function 73 Prevent Stroke 73 Non Inferiority 73 Colorectal Cancers 73 Urinary Incontinence 73 Oral Anticoagulant 73 Breast Cancers 73 Cognitive Impairment 73 Initiates Phase II 73 Therapy Reduces 73 Acute Ischemic Stroke 73 Antidepressants Linked 73 Initiates Phase III 73 Tyrosine Kinase Inhibitor 73 Oral Presentations 73 Chronic Lymphocytic Leukemia 73 Blood Thinner 73 Vaccine Protects Against 73 Teva Provides Update 73 Study Shows Promise 73 Schizophrenia Drug 73 Virus Linked 73 Inhibits 73 Circulating Tumor Cells 73 Breast Cancer Cells 73 Present Preclinical Data 73 Visceral Fat 73 Heartburn Drugs 73 Test Detects 73 IND Application 73 ST Elevation Myocardial 73 Anticancer Drug 73 Blind Placebo Controlled Trial 73 Vicriviroc 73 Antigen Specific 73 Hematological Cancers 73 Mg Uk 73 Phase Ib Clinical Trial 73 Hip Fractures 73 Non Invasive Treatment 73 Liver Tumors 73 Antitumor 73 Interferon Beta 73 Therapeutic Efficacy 73 Prospective Multicenter 73 Pivotal Trials 73 Oral Cladribine 73 Anti Clotting Drug 73 Cognitive Decline 73 Expanded Indication 73 RNAi Therapeutic 73 Diabetic Neuropathy 73 Achieves Primary Endpoint 73 Bazedoxifene 73 Clinical Efficacy 73 Gastric Ulcers 73 Aggressive Prostate Cancer 73 Prolongs Life 73 Pre Cancerous 73 Levels Linked 73 Nilotinib 73 Recurrent Breast Cancer 73 Pegylated Interferon 73 Multicenter Study 73 Patient Outcomes 73 Pivotal Clinical Trial 73 Cholesterol Levels 73 Cholesterol Drugs 73 Catheter Ablation 73 Prostate Cancer Vaccine 73 Peginterferon Alfa 2b 73 Lipid Levels 73 Submits NDA 73 Bipolar Depression 73 Dose Response 73 Sirolimus Eluting 73 Advanced Pancreatic Cancer 73 Generalized Anxiety Disorder 73 Migraine Headaches 73 Protein Linked 73 Adefovir 73 TNF Blockers 73 ST Segment Elevation 73 Cardiotoxicity 73 Intravenous Formulation 73 Viral Load 73 FDA Approves Drug 73 Glatiramer Acetate 73 Breast Carcinoma 73 Reduces Risk 73 Asthma Treatment 73 Atypical Antipsychotics 73 Gene Mutations 73 Ozarelix 73 Prostate Cancer Treatment 73 Drug Coated Stents 73 Enlarged Prostate 73 Mouse Models 73 Guidelines Recommend 73 Genetic Variations 73 Lymph Nodes 73 Antiplatelet Therapy 73 Left Ventricular 73 Ranolazine 73 Hepatitis C Treatment 73 Antiplatelet 73 Depressive Symptoms 73 Sipuleucel T 73 Cholesterol Lowering Drugs 73 Long Term Survival 73 Newly Diagnosed Patients 73 PRN FDA Approves 73 Thromboembolism 73 Protease Inhibitors 73 Drug Regimen 72 Thiazolidinediones 72 Stent Thrombosis 72 Bone Fracture 72 Hepatitis C Genotype 72 Inflammatory Arthritis 72 Autoimmune Disease 72 Successfully Treated 72 Safinamide 72 Glufosfamide 72 Oral Calcitonin 72 ORLive Presents 72 Acute Myocardial Infarction 72 Hepatitis B Vaccine 72 Immune Cells 72 Symptom Relief 72 Demonstrate Significant 72 Respiratory Distress 72 Aflibercept 72 Lowering Blood Pressure 72 Oral Cavity 72 Genetic Variants 72 Contrast Agents 72 Stem Cell Treatment 72 Brain Atrophy 72 Eur J 72 Allergic Rhinitis 72 Chemotherapeutic Agents 72 Atypical Hemolytic Uremic Syndrome 72 Chronic HCV 72 Crit Rev 72 Inhaled Nitric Oxide 72 Attenuates 72 Diabetic Foot Ulcers 72 Vitro Activity 72 Disease Modifying 72 Initiates Phase 72 Bosutinib 72 Genetic Variation 72 Endometrial Cancer 72 Capsules CII 72 Phospholipase A2 72 Polymerase Inhibitor 72 Orthostatic Hypotension 72 Renal Impairment 72 Cancer Recurrence 72 Novel Treatments 72 Reduces Mortality 72 Late Breaker 72 Lowers Blood Pressure 72 Cocaine Addiction 72 Male Contraceptive 72 Medoxomil 72 Preclinical Models 72 Panic Disorder 72 Plaque Psoriasis 72 Shows Promise 72 Insulin Resistance 72 Cell Transplants 72 Improve Outcomes 72 Synthetic Peptide 72 Diabetic Foot Ulcer 72 Viral Infections 72 Survival Rates 72 Bone Fractures 72 Antidepressant Use 72 HDAC Inhibitor 72 Nat Clin Pract 72 Skin Lesions 72 Blood Pressure Drugs 72 Squamous Cell Carcinoma 72 Antibiotic Treatment 72 Generic Version 72 Commences Phase 72 Neuroprotective Effects 72 Higher Doses 72 Novel Method 72 Elagolix 72 Dementia Patients 72 Observational Study 72 Treat Heart Failure 72 Combination Clinical Trial 72 Helps Predict 72 Topical Treatment 72 Develop Novel 72 Potent Antiviral Activity 72 Epidermal Growth Factor Receptor 72 Anemia Drug 72 Generic Versions 72 Cholesterol Lowering 72 Pegylated Liposomal Doxorubicin 72 Viral Suppression 72 Vertebral Fracture 72 Immunomodulatory 72 Presents Preclinical Data 72 IIa Clinical Trial 72 Coronary Artery Calcium 72 Phase III Pivotal 72 Balloon Angioplasty 72 Inflammatory Disease 72 Perifosine KRX 72 Neoadjuvant 72 Commonly Used 72 Infarct 72 Prostate Cancer Recurrence 72 Immunogenicity 72 By JENNIFER LEARN 72 Lanthanum Carbonate 72 Drug Coated Stent 72 Unstable Angina 72 Genetic Markers 72 FDA Accepts 72 Pharmacyclics Announces 72 Prognostic Value 72 CYP#A# CYP#D# 72 Systemic Delivery 72 Cardiac Biomarkers 72 Immune Cell 72 Adjunctive Treatment 72 Collaborators Present 72 Primary Endpoint 72 Septic Shock 72 Mimetics 72 #-# Full Text 72 Randomised 72 Poster Presentations 72 Therapy Shows Promise 72 Induces 72 Prostate Biopsy 72 Renal Cancer 72 Therapeutic Vaccine 72 Novel Compounds 72 Leukemia Cells 71 Obese Teens 71 Comorbidities 71 Immunosuppression 71 Endovascular Treatment 71 Testosterone Patch 71 Treat Anemia 71 Diuretic 71 Psoriasis Drug 71 Initiate Clinical Trial 71 Significantly Improved 71 Poorly Controlled 71 Transplant Patients 71 Gum Disease 71 Medullary Thyroid Cancer 71 Acute Myocardial 71 Gastrointestinal Stromal Tumors 71 Human Monoclonal Antibody 71 Cancer Treatments 71 Mesothelioma Treatment 71 Lung Tumors 71 Statins Reduce 71 Antifungals 71 Antipsychotic Medications 71 J Allergy Clin 71 Acute Heart Failure 71 Cervical Cancer Vaccine 71 Refractory Angina 71 Skeletal Muscle 71 Smoking Linked 71 Pegylated 71 Genetic Mutation 71 Tigecycline 71 Ovarian Cancers 71 Fulvestrant 71 Chemotherapy Regimen 71 Molecular Diagnostic Test 71 Non Alcoholic Fatty 71 Adenoma 71 Boosts Survival 71 Colorectal Cancer Risk 71 Hepatitis C Virus 71 Efficacious 71 MEK Inhibitor 71 Significantly Reduces 71 Non Responders 71 First Patient Treated 71 Shows Statistically Significant 71 Treatment Naive 71 Minimally Invasive Treatment 71 Anthrax Toxin 71 Anticancer Agent 71 Predict Response 71 Genital Warts 71 Adjuvant Breast Cancer 71 IND Filing 71 Menopausal Symptoms 71 Breast Density 71 Hypercholesterolemia 71 Blood Clots 71 Sapacitabine 71 Beta Blocker 71 Initiated Phase 71 Bevacizumab 71 Mycophenolate Mofetil 71 Seasonal Influenza Vaccine 71 Chemoradiation 71 Preterm Delivery 71 Preterm Labor 71 Abstracts Accepted 71 Antipsychotic Drug 71 Percutaneous Tibial Nerve Stimulation 71 Carotid Endarterectomy 71 Estrogen Therapy 71 Biogen Genentech 71 Myocardial Ischemia 71 Epoetin Alfa 71 Preclinical Efficacy 71 Capecitabine 71 Heart Stents 71 Surgical Procedures 71 Leukemias 71 Bone Mineral Density 71 Guidelines Issued 71 Hernia Repair 71 Clinical Evaluation 71 TO AVOID PREGNANCY WHILE 71 Genotypes 71 Hepatitis B Virus 71 Pain Relievers 71 Nuvelo Announces 71 Adenomas 71 Laryngeal Cancer 71 Nebulized 71 Paraplatin ® 71 Chronic Cough 71 Migraine Pain 71 Survival Rate 71 FDA APPROVES 71 Aurora Kinase 71 Liver Damage 71 Neuroendocrine Tumors 71 alfa 2a 71 Renal Artery 71 Prove Effective 71 Myocardial Infarction Study 71 Randomized Placebo Controlled 71 Fondaparinux 71 Genetic Tests 71 HCV Genotype 71 Novel Therapeutic 71 Prostate Cancer Survival 71 Allergic Reactions 71 Prostate Tumors 71 JAK2 Inhibitor 71 Shingles Vaccine 71 Stem Cell Procedure 71 Signaling Pathway 71 Colon Polyps 71 Tumor Cells 71 Milestone Payment 71 Physical Function 71 dependent kinase inhibitor 71 Spinal Fractures 71 Vasomotor Symptoms 71 Initiates Enrollment 71 Valopicitabine 71 Sustained Reduction 71 Randomized Comparison 71 Chronic Heart Failure 71 Diffuse Large B 71 Beta Blockers 71 Brain Scans 71 Treatment Naive HIV 71 Commonly Prescribed 71 Cholinesterase Inhibitors 71 Pharmacokinetics PK 71 J Clin 71 evaluating mipomersen 71 Liver Injury 71 Community Acquired Pneumonia 71 SPRYCEL ® 71 Progenitor Cells 71 Insulin Pen 71 Virus Infection 71 See WARNINGS 71 Improves Quality 71 Skin Cancers 71 Blood Cancers 71 Malignant Glioma 71 Significant Reduction 71 Curr Opin 71 AnaSpec Introduces 71 Albuferon TM 71 Rectal Cancer 71 Radiofrequency Ablation 71 Enoxaparin 71 Trodusquemine MSI 71 Implantable Device 71 Epratuzumab 70 Gene Therapy Trial 70 Foot Ankle 70 Diagnostic Tests 70 Confirms Efficacy 70 Fluorouracil 70 Myelofibrosis 70 Seasonal Allergic Rhinitis 70 Pregnancy Linked 70 Effective Treatments 70 Total Knee Arthroplasty 70 Tipranavir 70 Eluting Stent 70 Anti CD# Antibody 70 Stem Cell Transplants 70 Study Evaluates 70 Chronic Inflammation 70 Smallpox Vaccine 70 Dual Antiplatelet Therapy 70 Hepatocellular 70 Osteoarthritis Patients 70 Left Ventricular Dysfunction 70 Protein Involved 70 Chemotherapy Improves 70 Surgical Treatment 70 RNAi Therapeutics 70 Moderate Drinking 70 Anticoagulant 70 Uterine Fibroid Embolization 70 Endothelial Cells 70 Radiation Induced 70 Tumor Response 70 Cardiol 70 Blood Clot Risk 70 Vaccine Prevents 70 Telithromycin 70 Oral Formulation 70 Significantly Improves 70 Novel Compound 70 Impairs 70 Pneumococcal Vaccine 70 Targeted Therapies 70 Cytotoxicity 70 Potentially Deadly 70 Prevent Fractures 70 Cardiovascular Mortality 70 Calcium Vitamin D 70 Weight Loss Drug 70 CYT# potent vascular disrupting 70 Dasatinib 70 Data Suggest 70 Calcium Supplements 70 Study Shows Benefits 70 Testosterone Gel 70 FDA Panel Recommends 70 Receives Orphan Drug 70 Invasive Fungal Infections 70 Data Indicate 70 J Am Acad 70 Liver Toxicity 70 Multicenter 70 Acute Migraine 70 Respiratory Syncytial Virus 70 Taro Receives 70 Migraine Treatment 70 Contrast Agent 70 Tumor Targeting 70 complement inhibitor eculizumab 70 Randomized Placebo controlled 70 Who Underwent 70 MRSA Infections 70 Randomised Controlled Trial 70 Acute Coronary Syndromes 70 Drug Eluting 70 Lymph Node 70 Safety Tolerability 70 Epileptic Seizures 70 Clinically Significant 70 Fast Track Status 70 Parathyroid Hormone 70 Selective Cardiac Myosin 70 Receptor Antagonist 70 Cancer Incidence Mortality 70 Multicenter Double 70 Patient Accrual 70 Hepatic Encephalopathy 70 Therapeutic Vaccines 70 Insulin Sensitivity 70 Blocked Arteries 70 Prostate Cancers 70 Sinus Infections 70 Recurrent Ovarian Cancer 70 Pancreatic Adenocarcinoma 70 Antifungal 70 Treating Depression 70 Thyroid Hormone 70 Hydrochlorothiazide Tablets 70 Vertebral Compression Fractures 70 REMINDER ORLive Presents 70 Oral Insulin 70 Antidepressant Drug 70 Neovascular Age Related Macular 70 EntreMed Presents 70 Aliskiren 70 Demonstrates Statistically Significant 70 Treatment Regimens 70 Anticancer Compound 70 Vitamin D Linked 70 Juvenile Idiopathic Arthritis 70 Organ Rejection 70 Monoclonal Antibody 70 Reduce Mortality 70 Regimens 70 Genetic Mutations 70 Limb Ischemia 70 Progressive Multifocal Leukoencephalopathy 70 Cilostazol 70 Asthma Symptoms 70 Atopic Dermatitis 70 B Cell Lymphoma 70 Postherpetic Neuralgia 70 TRANSFORMS 70 Inflammatory Diseases 70 Prostate Cancer Progression 70 BioElectronics Announces 70 Orthop Surg 70 Therapeutic Targets 70 Inhaled Insulin 70 Endovascular Repair 70 Diagnostic Criteria 70 Carboplatin Paclitaxel 70 Initiates Phase 2b 70 Prenatal Exposure 70 Heart Transplant Recipients 70 Psychiatric Disorders 70 Blood Vessels 70 Interferon Gamma 70 Suppl. 70 Malaria Vaccine 70 Could Predict 70 Psoriasis Patients 70 Blood Thinning 70 Melphalan 70 Brain Aneurysms 70 Primary Hypercholesterolemia 70 Factor Receptor 70 Postmenopausal 70 Am J Clin 70 Rare Genetic 70 Acute Exacerbations 70 Aortic Stenosis 70 Fecal Incontinence 70 Aggressive Reduction 70 Eculizumab 70 Brain Shrinkage 70 Venous Thrombosis 70 Lung Infections 70 Intravitreal 70 Nephrol Dial Transplant 70 Prevent Breast Cancer 70 Atypical Antipsychotic 70 FDA Warns Against 70 Minimally Invasive Procedure 70 Adenoviral 70 familial amyloidotic polyneuropathy FAP 70 Demonstrates Potential 70 Peptic Ulcer 70 Blood Pressure Lowering 70 Clin Oncol 70 Humanized Anti 70 Initiates Clinical 70 Pulmonary Artery 70 Receptor Antagonists 70 PEGylated Fab fragment 70 Cardiovascular Disease Risk 70 Physician Insights 70 Thrombotic 70 Receives Approvable Letter 70 Ischemic 70 Syncria R 70 Trial Halted 70 Anthracycline 70 Hepatotoxicity 70 Prospective Cohort Study 70 Hyperlipidemia 70 Conjugate 70 PEGINTRON TM 70 Allergic Asthma 70 IN PATIENTS WITH 69 Ovary Removal 69 Muscle Function 69 J Shoulder Elbow 69 Int J Obes Relat 69 Healthbeat Report 69 Skin Structure Infections 69 Brain Tumor Patients 69 Cognitive Problems 69 Bladder Cancer 69 Neovascularization 69 J Pediatr